Additive effects of intravenous and intravesical application of vibegron, a β3-adrenoceptor agonist, on bladder function in rats with bladder overactivity-Reference-Cited by-同舟云学术

Additive effects of intravenous and intravesical application of vibegron, a β3-adrenoceptor agonist, on bladder function in rats with bladder overactivity

Published:2020-06-18 Issue:11 Volume:393 Page:2073-2080
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmiedeberg's Arch Pharmacol

Author:

Furuta Akira^ORCID,Suzuki Yasuyuki,Igarashi Taro,Koike Yusuke,Kimura Takahiro,Egawa Shin,Yoshimura Naoki

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00210-020-01921-2.pdf

Reference15 articles.

1. Birder LA, Nealen ML, Kiss S, de Groat WC, Caterina MJ, Wang E, Apodaca G, Kanai AJ (2002) Beta-adrenoceptor agonists stimulate endothelial nitric oxide synthase in rat urinary bladder urothelial cells. J Neurosci 22:8063–8070

2. Coelho A, Antunes-Lopes T, Gillespie J, Cruz F (2017) Beta-3 adrenergic receptor is expressed in acetylcholine-containing nerve fibers of the human urinary bladder: an immunohistochemical study. Neurourol Urodyn 36:1972–1980. https://doi.org/10.1002/nau.23224

3. D’ Agostino G, Maria Condino A, Calvi P (2015) Involvement of beta3-adrenoceptors in the inhibitory control of cholinergic activity in human bladder: direct evidence by [(3)H]-acetylcholine release experiments in the isolated detrusor. Eur J Pharmacol 758:115–122. https://doi.org/10.1016/j.ejphar.2015.03.074

4. Edmondson SD, Zhu C, Kar NF, di Salvo J, Nagabukuro H, Sacre-Salem B, Dingley K, Berger R, Goble SD, Morriello G, Harper B, Moyes CR, Shen DM, Wang L, Ball R, Fitzmaurice A, Frenkl T, Gichuru LN, Ha S, Hurley AL, Jochnowitz N, Levorse D, Mistry S, Miller RR, Ormes J, Salituro GM, Sanfiz A, Stevenson AS, Villa K, Zamlynny B, Green S, Struthers M, Weber AE (2016) Discovery of vibegron: a potent and selective beta3 adrenergic receptor agonist for the treatment of overactive bladder. J Med Chem 59:609–623. https://doi.org/10.1021/acs.jmedchem.5b01372

5. Furuta A, Suzuki Y, Kimura S, Koike Y, Egawa S, Yoshimura N (2016) Combination therapy with beta3 -adrenoceptor agonists and muscarinic acetylcholine receptor antagonists: efficacy in rats with bladder overactivity. Int J Urol 23:425–430. https://doi.org/10.1111/iju.13066

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiology of Overactive Bladder and Pharmacologic Treatments Including β3-Adrenoceptor Agonists -Basic Research Perspectives-;International Neurourology Journal;2024-02-29

2. Effects of a new selective β₃‐adrenoceptor agonist, vibegron, on bladder and urethral function in a rat model of Parkinson's disease;LUTS: Lower Urinary Tract Symptoms;2023-09-18

3. Stress Urinary Incontinence: An Unsolved Clinical Challenge;Biomedicines;2023-09-07

4. Inhibitory effects of vibegron, a β3-adrenoceptor agonist, on the myogenic contractile and mechanosensitive afferent activities in an obstructed rat bladder;European Journal of Pharmacology;2022-10

5. Urothelial Calcium-Sensing Receptor Modulates Micturition Function via Mediating Detrusor Activity and Ameliorates Bladder Hyperactivity in Rats;Pharmaceuticals;2021-09-23